Fralick Celeste Rachelle 4
4 · Aspira Women's Health Inc. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
Fralick Celeste Rachelle
Director
Transactions
- Exercise/Conversion
Common Stock
2024-09-30+5,000→ 45,665 total - Exercise/Conversion
Restricted Stock Units
2024-09-30−5,000→ 15,000 total→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
- [F2]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
- [F3]On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.